Lightchain Capital

Recent News

C4-logo-400
August 02, 2022

C4 Therapeutics Appoints Experienced Clinical Development Leaders Laura Bessen, M.D. and Donna Grogan, M.D. to Board of Directors

READ MORE
wugen-logo-400
July 19, 2022

Wugen Receives U.S. FDA Fast Track and Rare Pediatric Disease Designations for WU-CART-007 for the Treatment of R/R T-ALL/LBL

READ MORE
Logo-Geneoscopy-400
July 19, 2022

Geneoscopy to Join Fight CRC at the White House to Address Colorectal Cancer Screening Needs

READ MORE
Logo-Geneoscopy-400
July 19, 2022

Geneoscopy to Join Fight CRC at the White House to Address Colorectal Cancer Screening Needs

READ MORE
Logo-Geneoscopy-400
June 21, 2022

Geneoscopy Announces Formation of Scientific Advisory Board to Inform Strategy for the Advancement of Gastrointestinal Health

READ MORE
Logo-Geneoscopy-400
June 21, 2022

Geneoscopy Announces Formation of Scientific Advisory Board to Inform Strategy for the Advancement of Gastrointestinal Health

READ MORE
CareVet-Logo-New
June 14, 2022

CEO of St. Louis-based vet manager named regional Entrepreneur of the Year winner

READ MORE
wugen-logo-400
June 10, 2022

Wugen Presents New Preclinical Data Demonstrating Enhanced Anti-Tumor Activity of WU-NK-101 at the European Hematology Association (EHA) 2022 Hybrid Congress

READ MORE
wugen-logo-400
June 01, 2022

Wugen to Participate in Upcoming June Investor Conferences

READ MORE

Contact Us

Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131

 

LinkedIn

Submit

©2024 LIGHTCHAIN CAPITAL, LLC  All Rights Reserved | Privacy Policy
Website by Tidal Media Group